Page last updated: 2024-08-24

cephalosporin c and telavancin

cephalosporin c has been researched along with telavancin in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (50.00)29.6817
2010's6 (42.86)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
de Roux, A; Lode, H; Schmidt-Ioanas, M1
Hawser, SP1
Loffler, CA; Macdougall, C1
Micek, ST; Neuner, EA; Ritchie, DJ1
Cabeza, J; Carrasco, C; Gutierrez, J; Sorlozano, A; Villegas, E1
Eliopoulos, GM1
Cattoir, V; Daurel, C1
Kollef, MH1
Appelbaum, PC; Ednie, LM; Lin, G; Pankuch, GA1
Wilcox, MH1
Graviss, EA; Marconescu, P; Musher, DM1
Muscedere, J1
Mensa, J; Morata, L; Soriano, A1
Epps, KL; Epps, QJ; Young, DC; Zobell, JT1

Reviews

8 review(s) available for cephalosporin c and telavancin

ArticleYear
New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
    Current opinion in critical care, 2005, Volume: 11, Issue:5

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Critical Illness; Daptomycin; Drug Resistance, Multiple, Bacterial; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Virginiamycin

2005
New antibiotics for healthcare-associated pneumonia.
    Seminars in respiratory and critical care medicine, 2009, Volume: 30, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Cross Infection; Doripenem; Glycopeptides; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Bacterial; Pseudomonas Infections; Pyrimidines; Staphylococcal Infections; Teicoplanin

2009
Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria.
    The Journal of infection, 2009, Volume: 59 Suppl 1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Teicoplanin; Vancomycin

2009
[Update on antimicrobial chemotherapy].
    Medecine et maladies infectieuses, 2010, Volume: 40, Issue:3

    Topics: Acetamides; Aminoglycosides; Anti-Infective Agents; beta-Lactams; Carbapenems; Cephalosporins; Daptomycin; Doripenem; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; France; Humans; Linezolid; Lipoglycopeptides; Minocycline; Oxazolidinones; Penicillins; Pyrimidines; Teicoplanin; Tigecycline

2010
New antimicrobial agents for methicillin-resistant Staphylococcus aureus.
    Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2009, Volume: 11, Issue:4

    Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Glycopeptides; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pyrimidines; Staphylococcal Infections; Teicoplanin

2009
MRSA new treatments on the horizon: current status.
    Injury, 2011, Volume: 42 Suppl 5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Glycopeptides; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Teicoplanin

2011
New antibiotics against gram-positives: present and future indications.
    Current opinion in pharmacology, 2015, Volume: 24

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Oxazoles

2015
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
    Pediatric pulmonology, 2020, Volume: 55, Issue:1

    Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin-Resistant Staphylococcus aureus; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin

2020

Other Studies

6 other study(ies) available for cephalosporin c and telavancin

ArticleYear
Antibacterial drug discovery and development--SRI's 11th Annual Summit.
    IDrugs : the investigational drugs journal, 2006, Volume: 9, Issue:6

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Clinical Trials as Topic; Drug Design; Humans; Incidence; Lipoglycopeptides; Methicillin Resistance; Minocycline; Molecular Structure; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Thiazoles; Tigecycline

2006
Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
    Expert review of anti-infective therapy, 2007, Volume: 5, Issue:6

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Daptomycin; Doxycycline; Folic Acid Antagonists; Global Health; Glycopeptides; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin Resistance; Minocycline; Oxazolidinones; Prevalence; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Teicoplanin; Tigecycline; Trimethoprim; Vancomycin

2007
Antimicrobial development in the era of emerging resistance.
    Mini reviews in medicinal chemistry, 2009, Volume: 9, Issue:8

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cephalosporins; Drug Approval; Drug Resistance, Bacterial; Glycopeptides; Humans; Lipoglycopeptides; Pyrimidines; Skin Diseases, Bacterial; Skin Diseases, Viral; Teicoplanin; United States; United States Food and Drug Administration

2009
Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Synergism; Gentamicins; Lipoglycopeptides; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Rifampin; Thienamycins; Time Factors

2010
Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin.
    Scandinavian journal of infectious diseases, 2012, Volume: 44, Issue:8

    Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Colony Count, Microbial; Daptomycin; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Vancomycin

2012
Which antibiotic for hospital acquired pneumonia caused by MRSA?
    BMJ (Clinical research ed.), 2014, Feb-13, Volume: 348

    Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin

2014